Operational Aspects of Data Monitoring Committees
May 26, 2011
IDDI organized a webinar on Operational Aspects of Data Monitoring Committees.
The webinar explored best practices that have emerged during this time. The emphasis was on the safety monitoring responsibilities of data monitoring committees in the pharma industry.
- The webinar showed how practices and issues vary over these three strata. Organizational issues, meetings, clinical issues, useful statistical methods, biases and pitfalls, DMC decisions and emerging issues including adaptive designs and cost control were covered. The issues were illustrated by actual behind-the-scenes scenarios providing rare look at DMC practices.
- Dr. Jay Herson, Senior Associate, Biostatistics, Johns Hopkins University Baltimore, Maryland USA. Dr. Herson, a collaborator of IDDI, will draw on his 25-year experience with data monitoring committees (DMC) in the pharmaceutical industry which led to his book Data and Safety Monitoring Committees in Clinical Trials published by Chapman and Hall/CRC in 2009
TO ACCESS THE PRESENTATION OF THIS ON-DEMAND WEBINAR, PLEASE FILL OUT THE FORM BELOW